Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Consensus Recommendation of “Reduce” from Analysts

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has received an average rating of “Reduce” from the six analysts that are currently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $1.80.

Separately, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Aveanna Healthcare from $2.00 to $3.00 and gave the stock a “buy” rating in a research note on Monday, March 18th.

Aveanna Healthcare Stock Performance

Shares of NASDAQ:AVAH opened at $2.40 on Friday. The stock has a market capitalization of $461.71 million, a price-to-earnings ratio of -3.38 and a beta of 2.03. Aveanna Healthcare has a 1-year low of $0.85 and a 1-year high of $3.00. The company has a 50 day moving average price of $2.41 and a 200 day moving average price of $2.16.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Thursday, March 14th. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.02. The business had revenue of $478.84 million for the quarter, compared to the consensus estimate of $464.33 million. On average, sell-side analysts expect that Aveanna Healthcare will post -0.13 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in shares of Aveanna Healthcare during the 2nd quarter valued at $25,000. Lazard Asset Management LLC bought a new position in Aveanna Healthcare in the 2nd quarter worth $26,000. Citigroup Inc. raised its holdings in Aveanna Healthcare by 6,083.2% in the 2nd quarter. Citigroup Inc. now owns 15,458 shares of the company’s stock worth $26,000 after acquiring an additional 15,208 shares during the period. Deutsche Bank AG raised its holdings in Aveanna Healthcare by 67.8% in the 1st quarter. Deutsche Bank AG now owns 26,882 shares of the company’s stock worth $28,000 after acquiring an additional 10,863 shares during the period. Finally, Creative Planning bought a new position in Aveanna Healthcare in the 4th quarter worth $31,000. Institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.